{"schema_version":"secwatch.filing_event.v1","accession":"0001386570-26-000014","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.963715+00:00","generated_at":"2026-05-15T21:34:57.025760+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Niagen Bioscience reports 30% net sales growth to $129.4M in 2025; net income up 103% to $17.4M","bullets":["Full year 2025 net sales $129.4M (+30% YoY); net income $17.4M (+103%); adjusted EBITDA $20.4M (+139%).","Q4 net sales $33.8M (+16% YoY); Q4 net income $4.1M vs $7.2M prior; Q4 adjusted EBITDA $4.1M (+$0.7M).","Gross margin improved 250 bps to 64.3% for year; cash $64.8M at Dec 31, 2025.","FY 2026 net sales outlook 10-15% growth ex. reference standards segment sold in Feb 2026 for ~$6M.","Acquired foundational NR patent portfolio from Queen’s University Belfast (Dec 2025); launched Tru Niagen Beauty (Nov 2025)."],"urls":{"canonical":"https://secwatch.observer/filing/0001386570-26-000014","json":"https://secwatch.observer/filing/0001386570-26-000014.json","markdown":"https://secwatch.observer/filing/0001386570-26-000014.md","text":"https://secwatch.observer/filing/0001386570-26-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000014/0001386570-26-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000014/cdxc-20260304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:34:57.025760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}